Crinetics Pharmaceuticals, Inc. Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss
Crinetics Pharmaceuticals, Inc. (CRNX) had Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss of $67.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss · last filed 2025-11-06
- 2025-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $67.00K.
- 2024-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $274.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss |
|---|---|
| 2025-09-30 | $67.00K 10-Q · filed 2025-11-06 |
| 2024-12-31 | $274.00K 10-Q · filed 2025-11-06 |